A Conformational Intermediate in Glutamate Receptor Activation

Ionotropic glutamate receptors (iGluRs) transduce the chemical signal of neurotransmitter release into membrane depolarization at excitatory synapses in the brain. The opening of the transmembrane ion channel of these ligand-gated receptors is driven by conformational transitions that are induced by...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuron (Cambridge, Mass.) Mass.), 2013-08, Vol.79 (3), p.492-503
Hauptverfasser: Lau, Albert Y., Salazar, Héctor, Blachowicz, Lydia, Ghisi, Valentina, Plested, Andrew J.R., Roux, Benoît
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 503
container_issue 3
container_start_page 492
container_title Neuron (Cambridge, Mass.)
container_volume 79
creator Lau, Albert Y.
Salazar, Héctor
Blachowicz, Lydia
Ghisi, Valentina
Plested, Andrew J.R.
Roux, Benoît
description Ionotropic glutamate receptors (iGluRs) transduce the chemical signal of neurotransmitter release into membrane depolarization at excitatory synapses in the brain. The opening of the transmembrane ion channel of these ligand-gated receptors is driven by conformational transitions that are induced by the association of glutamate molecules to the ligand-binding domains (LBDs). Here, we describe the crystal structure of a GluA2 LBD tetramer in a configuration that involves an ∼30° rotation of the LBD dimers relative to the crystal structure of the full-length receptor. The configuration is stabilized by an engineered disulfide crosslink. Biochemical and electrophysiological studies on full-length receptors incorporating either this crosslink or an engineered metal bridge show that this LBD configuration corresponds to an intermediate state of receptor activation. GluA2 activation therefore involves a combination of both intra-LBD (cleft closure) and inter-LBD dimer conformational transitions. Overall, these results provide a comprehensive structural characterization of an iGluR intermediate state. •The crystal structure of a GluA2 LBD tetramer captures an activation intermediate•Glutamate-binding domain dimers rotate by ?30° during activation•A disulfide bond between subunits traps a partially activated state•Trapping by engineered metal bridges confirms the conformational arrangement Lau et al. show that an intermediate state in the activation pathway of AMPARs, a class of ionotropic glutamate receptors, involves an ∼30° rotation between the two ligand-binding domain dimers.
doi_str_mv 10.1016/j.neuron.2013.06.003
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3814226</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0896627313004947</els_id><sourcerecordid>1560110160</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-80d1fbd68ee2988d5ce0ba767df1c332e81acc82af8d53abaa1b1abc2b373b453</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxUVJabZpv0EJhlx6sauRbFm-BJYlTQOBQmnPQpbHiRZb2kjyQr59tN00_XPoSQzzm6c38wj5ALQCCuLTtnK4BO8qRoFXVFSU8ldkBbRryxq67oSsqOxEKVjLT8nbGLeUQt108IacMt7xjMgVuVwXG-9GH2adrHd6Km5cwjDjYHXCwrrielqSng_FNzS4Sz4Ua5Ps_if_jrwe9RTx_fN7Rn58vvq--VLefr2-2axvS9OwOpWSDjD2g5CIrJNyaAzSXreiHUYwnDOUoI2RTI-5x3WvNfSge8N63vK-bvgZuTzq7pY-ezPoUtCT2gU76_CovLbq746z9-rO7xWXUDMmssDHZ4HgHxaMSc02Gpwm7dAvUUEjKBzuSjN68Q-69UvIp8mUyF5qWXOWqfpImeBjDDi-mAGqDkJqq44BqUNAigqVA8pj538u8jL0K5Hfm2I-595iUNFYdCYHEtAkNXj7_x-eAGMapQ8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1645348432</pqid></control><display><type>article</type><title>A Conformational Intermediate in Glutamate Receptor Activation</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Lau, Albert Y. ; Salazar, Héctor ; Blachowicz, Lydia ; Ghisi, Valentina ; Plested, Andrew J.R. ; Roux, Benoît</creator><creatorcontrib>Lau, Albert Y. ; Salazar, Héctor ; Blachowicz, Lydia ; Ghisi, Valentina ; Plested, Andrew J.R. ; Roux, Benoît</creatorcontrib><description>Ionotropic glutamate receptors (iGluRs) transduce the chemical signal of neurotransmitter release into membrane depolarization at excitatory synapses in the brain. The opening of the transmembrane ion channel of these ligand-gated receptors is driven by conformational transitions that are induced by the association of glutamate molecules to the ligand-binding domains (LBDs). Here, we describe the crystal structure of a GluA2 LBD tetramer in a configuration that involves an ∼30° rotation of the LBD dimers relative to the crystal structure of the full-length receptor. The configuration is stabilized by an engineered disulfide crosslink. Biochemical and electrophysiological studies on full-length receptors incorporating either this crosslink or an engineered metal bridge show that this LBD configuration corresponds to an intermediate state of receptor activation. GluA2 activation therefore involves a combination of both intra-LBD (cleft closure) and inter-LBD dimer conformational transitions. Overall, these results provide a comprehensive structural characterization of an iGluR intermediate state. •The crystal structure of a GluA2 LBD tetramer captures an activation intermediate•Glutamate-binding domain dimers rotate by ?30° during activation•A disulfide bond between subunits traps a partially activated state•Trapping by engineered metal bridges confirms the conformational arrangement Lau et al. show that an intermediate state in the activation pathway of AMPARs, a class of ionotropic glutamate receptors, involves an ∼30° rotation between the two ligand-binding domain dimers.</description><identifier>ISSN: 0896-6273</identifier><identifier>EISSN: 1097-4199</identifier><identifier>DOI: 10.1016/j.neuron.2013.06.003</identifier><identifier>PMID: 23931998</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Benzothiadiazines - pharmacology ; Biophysical Phenomena - drug effects ; Biophysical Phenomena - genetics ; Cell Line, Transformed ; Chemical bonds ; Crystal structure ; Crystallography, X-Ray - methods ; Cysteine - genetics ; Dithionitrobenzoic Acid - pharmacology ; Dose-Response Relationship, Drug ; Electric Stimulation ; Excitatory Amino Acid Antagonists - pharmacology ; Glutamic Acid - pharmacology ; Humans ; In Vitro Techniques ; Ligands ; Membrane Potentials - drug effects ; Membrane Potentials - genetics ; Models, Molecular ; Molecular Conformation ; Mutation ; Mutation - genetics ; Patch-Clamp Techniques ; Phenanthrolines - pharmacology ; Protein Structure, Tertiary - genetics ; Proteins ; Quinoxalines - pharmacology ; Receptors, Glutamate - chemistry ; Receptors, Glutamate - genetics ; Receptors, Glutamate - metabolism ; Uncoupling Agents - pharmacology</subject><ispartof>Neuron (Cambridge, Mass.), 2013-08, Vol.79 (3), p.492-503</ispartof><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 7, 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-80d1fbd68ee2988d5ce0ba767df1c332e81acc82af8d53abaa1b1abc2b373b453</citedby><cites>FETCH-LOGICAL-c524t-80d1fbd68ee2988d5ce0ba767df1c332e81acc82af8d53abaa1b1abc2b373b453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0896627313004947$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23931998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lau, Albert Y.</creatorcontrib><creatorcontrib>Salazar, Héctor</creatorcontrib><creatorcontrib>Blachowicz, Lydia</creatorcontrib><creatorcontrib>Ghisi, Valentina</creatorcontrib><creatorcontrib>Plested, Andrew J.R.</creatorcontrib><creatorcontrib>Roux, Benoît</creatorcontrib><title>A Conformational Intermediate in Glutamate Receptor Activation</title><title>Neuron (Cambridge, Mass.)</title><addtitle>Neuron</addtitle><description>Ionotropic glutamate receptors (iGluRs) transduce the chemical signal of neurotransmitter release into membrane depolarization at excitatory synapses in the brain. The opening of the transmembrane ion channel of these ligand-gated receptors is driven by conformational transitions that are induced by the association of glutamate molecules to the ligand-binding domains (LBDs). Here, we describe the crystal structure of a GluA2 LBD tetramer in a configuration that involves an ∼30° rotation of the LBD dimers relative to the crystal structure of the full-length receptor. The configuration is stabilized by an engineered disulfide crosslink. Biochemical and electrophysiological studies on full-length receptors incorporating either this crosslink or an engineered metal bridge show that this LBD configuration corresponds to an intermediate state of receptor activation. GluA2 activation therefore involves a combination of both intra-LBD (cleft closure) and inter-LBD dimer conformational transitions. Overall, these results provide a comprehensive structural characterization of an iGluR intermediate state. •The crystal structure of a GluA2 LBD tetramer captures an activation intermediate•Glutamate-binding domain dimers rotate by ?30° during activation•A disulfide bond between subunits traps a partially activated state•Trapping by engineered metal bridges confirms the conformational arrangement Lau et al. show that an intermediate state in the activation pathway of AMPARs, a class of ionotropic glutamate receptors, involves an ∼30° rotation between the two ligand-binding domain dimers.</description><subject>Benzothiadiazines - pharmacology</subject><subject>Biophysical Phenomena - drug effects</subject><subject>Biophysical Phenomena - genetics</subject><subject>Cell Line, Transformed</subject><subject>Chemical bonds</subject><subject>Crystal structure</subject><subject>Crystallography, X-Ray - methods</subject><subject>Cysteine - genetics</subject><subject>Dithionitrobenzoic Acid - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Electric Stimulation</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Glutamic Acid - pharmacology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Ligands</subject><subject>Membrane Potentials - drug effects</subject><subject>Membrane Potentials - genetics</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Mutation</subject><subject>Mutation - genetics</subject><subject>Patch-Clamp Techniques</subject><subject>Phenanthrolines - pharmacology</subject><subject>Protein Structure, Tertiary - genetics</subject><subject>Proteins</subject><subject>Quinoxalines - pharmacology</subject><subject>Receptors, Glutamate - chemistry</subject><subject>Receptors, Glutamate - genetics</subject><subject>Receptors, Glutamate - metabolism</subject><subject>Uncoupling Agents - pharmacology</subject><issn>0896-6273</issn><issn>1097-4199</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9r3DAQxUVJabZpv0EJhlx6sauRbFm-BJYlTQOBQmnPQpbHiRZb2kjyQr59tN00_XPoSQzzm6c38wj5ALQCCuLTtnK4BO8qRoFXVFSU8ldkBbRryxq67oSsqOxEKVjLT8nbGLeUQt108IacMt7xjMgVuVwXG-9GH2adrHd6Km5cwjDjYHXCwrrielqSng_FNzS4Sz4Ua5Ps_if_jrwe9RTx_fN7Rn58vvq--VLefr2-2axvS9OwOpWSDjD2g5CIrJNyaAzSXreiHUYwnDOUoI2RTI-5x3WvNfSge8N63vK-bvgZuTzq7pY-ezPoUtCT2gU76_CovLbq746z9-rO7xWXUDMmssDHZ4HgHxaMSc02Gpwm7dAvUUEjKBzuSjN68Q-69UvIp8mUyF5qWXOWqfpImeBjDDi-mAGqDkJqq44BqUNAigqVA8pj538u8jL0K5Hfm2I-595iUNFYdCYHEtAkNXj7_x-eAGMapQ8</recordid><startdate>20130807</startdate><enddate>20130807</enddate><creator>Lau, Albert Y.</creator><creator>Salazar, Héctor</creator><creator>Blachowicz, Lydia</creator><creator>Ghisi, Valentina</creator><creator>Plested, Andrew J.R.</creator><creator>Roux, Benoît</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20130807</creationdate><title>A Conformational Intermediate in Glutamate Receptor Activation</title><author>Lau, Albert Y. ; Salazar, Héctor ; Blachowicz, Lydia ; Ghisi, Valentina ; Plested, Andrew J.R. ; Roux, Benoît</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-80d1fbd68ee2988d5ce0ba767df1c332e81acc82af8d53abaa1b1abc2b373b453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Benzothiadiazines - pharmacology</topic><topic>Biophysical Phenomena - drug effects</topic><topic>Biophysical Phenomena - genetics</topic><topic>Cell Line, Transformed</topic><topic>Chemical bonds</topic><topic>Crystal structure</topic><topic>Crystallography, X-Ray - methods</topic><topic>Cysteine - genetics</topic><topic>Dithionitrobenzoic Acid - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Electric Stimulation</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Glutamic Acid - pharmacology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Ligands</topic><topic>Membrane Potentials - drug effects</topic><topic>Membrane Potentials - genetics</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Mutation</topic><topic>Mutation - genetics</topic><topic>Patch-Clamp Techniques</topic><topic>Phenanthrolines - pharmacology</topic><topic>Protein Structure, Tertiary - genetics</topic><topic>Proteins</topic><topic>Quinoxalines - pharmacology</topic><topic>Receptors, Glutamate - chemistry</topic><topic>Receptors, Glutamate - genetics</topic><topic>Receptors, Glutamate - metabolism</topic><topic>Uncoupling Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lau, Albert Y.</creatorcontrib><creatorcontrib>Salazar, Héctor</creatorcontrib><creatorcontrib>Blachowicz, Lydia</creatorcontrib><creatorcontrib>Ghisi, Valentina</creatorcontrib><creatorcontrib>Plested, Andrew J.R.</creatorcontrib><creatorcontrib>Roux, Benoît</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuron (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lau, Albert Y.</au><au>Salazar, Héctor</au><au>Blachowicz, Lydia</au><au>Ghisi, Valentina</au><au>Plested, Andrew J.R.</au><au>Roux, Benoît</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Conformational Intermediate in Glutamate Receptor Activation</atitle><jtitle>Neuron (Cambridge, Mass.)</jtitle><addtitle>Neuron</addtitle><date>2013-08-07</date><risdate>2013</risdate><volume>79</volume><issue>3</issue><spage>492</spage><epage>503</epage><pages>492-503</pages><issn>0896-6273</issn><eissn>1097-4199</eissn><abstract>Ionotropic glutamate receptors (iGluRs) transduce the chemical signal of neurotransmitter release into membrane depolarization at excitatory synapses in the brain. The opening of the transmembrane ion channel of these ligand-gated receptors is driven by conformational transitions that are induced by the association of glutamate molecules to the ligand-binding domains (LBDs). Here, we describe the crystal structure of a GluA2 LBD tetramer in a configuration that involves an ∼30° rotation of the LBD dimers relative to the crystal structure of the full-length receptor. The configuration is stabilized by an engineered disulfide crosslink. Biochemical and electrophysiological studies on full-length receptors incorporating either this crosslink or an engineered metal bridge show that this LBD configuration corresponds to an intermediate state of receptor activation. GluA2 activation therefore involves a combination of both intra-LBD (cleft closure) and inter-LBD dimer conformational transitions. Overall, these results provide a comprehensive structural characterization of an iGluR intermediate state. •The crystal structure of a GluA2 LBD tetramer captures an activation intermediate•Glutamate-binding domain dimers rotate by ?30° during activation•A disulfide bond between subunits traps a partially activated state•Trapping by engineered metal bridges confirms the conformational arrangement Lau et al. show that an intermediate state in the activation pathway of AMPARs, a class of ionotropic glutamate receptors, involves an ∼30° rotation between the two ligand-binding domain dimers.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23931998</pmid><doi>10.1016/j.neuron.2013.06.003</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0896-6273
ispartof Neuron (Cambridge, Mass.), 2013-08, Vol.79 (3), p.492-503
issn 0896-6273
1097-4199
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3814226
source MEDLINE; Cell Press Free Archives; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Benzothiadiazines - pharmacology
Biophysical Phenomena - drug effects
Biophysical Phenomena - genetics
Cell Line, Transformed
Chemical bonds
Crystal structure
Crystallography, X-Ray - methods
Cysteine - genetics
Dithionitrobenzoic Acid - pharmacology
Dose-Response Relationship, Drug
Electric Stimulation
Excitatory Amino Acid Antagonists - pharmacology
Glutamic Acid - pharmacology
Humans
In Vitro Techniques
Ligands
Membrane Potentials - drug effects
Membrane Potentials - genetics
Models, Molecular
Molecular Conformation
Mutation
Mutation - genetics
Patch-Clamp Techniques
Phenanthrolines - pharmacology
Protein Structure, Tertiary - genetics
Proteins
Quinoxalines - pharmacology
Receptors, Glutamate - chemistry
Receptors, Glutamate - genetics
Receptors, Glutamate - metabolism
Uncoupling Agents - pharmacology
title A Conformational Intermediate in Glutamate Receptor Activation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T15%3A34%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Conformational%20Intermediate%20in%20Glutamate%20Receptor%20Activation&rft.jtitle=Neuron%20(Cambridge,%20Mass.)&rft.au=Lau,%20Albert%C2%A0Y.&rft.date=2013-08-07&rft.volume=79&rft.issue=3&rft.spage=492&rft.epage=503&rft.pages=492-503&rft.issn=0896-6273&rft.eissn=1097-4199&rft_id=info:doi/10.1016/j.neuron.2013.06.003&rft_dat=%3Cproquest_pubme%3E1560110160%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1645348432&rft_id=info:pmid/23931998&rft_els_id=S0896627313004947&rfr_iscdi=true